Amino‐functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages

Specifically designed and functionalized nanoparticles hold great promise for biomedical applications. Yet, the applicability of nanoparticles is critically predetermined by their surface functionalization. Here we demonstrate that amino-functionalized polystyrene nanoparticles (PS-NH(2)) of ∼100 nm in diameter, but not carboxyl- or nonfunctionalized particles, trigger NLRP3 inflammasome activation and subsequent release of proinflammatory interleukin 1β (IL-1β) by human macrophages. PS-NH(2) induced time-dependent proton accumulation in lysosomes associated with lysosomal destabilization, release of cathepsin B, and damage of the mitochondrial membrane. Accumulation of mitochondrial reactive oxygen species was accompanied by oxidation of thioredoxin, a protein playing a central role in maintaining the cellular redox balance. Upon oxidation, thioredoxin dissociated from the thioredoxin-interacting protein (TXNIP). Liberated TXNIP, in turn, interacted with the NLRP3 protein, resulting in a conformational change of the pyrin domain of the NLRP3 protein, as was predicted by molecular modeling. Consequently, this prompted assembly of the NLRP3 inflammasome complex with recruitment and activation of caspase-1, inducing IL-1β release by cleavage of pro-IL-1β. The central role of the NLRP3 inflammasome for cytokine production was confirmed by in vitro knockdown of NLRP3 and of the adaptor protein ASC, confirming that other inflammasomes were not activated by PS-NH(2). The PS-NH(2)-mediated proinflammatory macrophage activation could be antagonized by the radical scavenger N-acetyl-L-cysteine, which prevented mitochondrial damage, caspase-1 activation, and the subsequent release of IL-1β. Our study reveals the molecular mechanism of NLRP3 inflammasome activation by amino-functionalized nanoparticles and suggests a strategy as to how such adverse effects could be antagonized.

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  Joel A. Swanson,et al.  Shaping cups into phagosomes and macropinosomes , 2008, Nature Reviews Molecular Cell Biology.

[3]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[4]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[5]  Katharina Landfester,et al.  Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.

[6]  A. Florence Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting , 2004, Journal of drug targeting (Print).

[7]  J. Xie,et al.  Iron oxide nanoparticle platform for biomedical applications. , 2009, Current medicinal chemistry.

[8]  K. Landfester,et al.  Preparation of Fluorescent Carboxyl and Amino Functionalized Polystyrene Particles by Miniemulsion Polymerization as Markers for Cells , 2005 .

[9]  A. Elaissari,et al.  Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .

[10]  J. Slupsky,et al.  cells human peripheral monocytes and monocyte-derived antigen-presenting Differential expression and regulation of protease-activated receptors in , 2013 .

[11]  J. Tschopp,et al.  Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal , 2009, PloS one.

[12]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[13]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[14]  V. Hornung,et al.  Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells , 2011, Nanotoxicology.

[15]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[16]  J. Tschopp,et al.  Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β , 2010, Proceedings of the National Academy of Sciences.

[17]  L. Yahia,et al.  Therapeutic potential of nanoparticulate systems for macrophage targeting. , 2005, Biomaterials.

[18]  Lazaros Mavridis,et al.  HexServer: an FFT-based protein docking server powered by graphics processors , 2010, Nucleic Acids Res..

[19]  P. Lipton,et al.  Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA‐mediated calcium influx, arachidonic acid metabolism, and free radical production , 2008, Journal of neurochemistry.

[20]  N. Suttorp,et al.  Innate immune recognition in infectious and noninfectious diseases of the lung. , 2010, American journal of respiratory and critical care medicine.

[21]  David M. Mosser,et al.  Exploring the full spectrum of macrophage activation , 2010, Nature Reviews Immunology.

[22]  T. Syrovets,et al.  Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. , 2006, Blood.

[23]  C. Röcker,et al.  Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. , 2010, ACS nano.

[24]  G. Gores,et al.  Lysosomes in cell death , 2004, Oncogene.

[25]  S. Adachi,et al.  Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells. , 2007, Blood.

[26]  T. Syrovets,et al.  The Serine Protease Plasmin Triggers Expression of MCP-1 and CD40 in Human Primary Monocytes via Activation of p38 MAPK and Janus Kinase (JAK)/STAT Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[27]  Dean P. Jones,et al.  Redox Potential of Human Thioredoxin 1 and Identification of a Second Dithiol/Disulfide Motif* , 2003, Journal of Biological Chemistry.

[28]  V. Rasche,et al.  Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. , 2010, Biomaterials.

[29]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[30]  Günter Oberdörster,et al.  A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study , 2009, Nanotoxicology.

[31]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[32]  Vincent M. Rotello,et al.  Self-assembly of nanoparticles into structured spherical and network aggregates , 2000, Nature.

[33]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[34]  J. Eaton,et al.  Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. , 2003, European journal of biochemistry.

[35]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[36]  G. Núñez,et al.  Pannexin-1-Mediated Intracellular Delivery of Muramyl Dipeptide Induces Caspase-1 Activation via Cryopyrin/NLRP3 Independently of Nod21 , 2008, The Journal of Immunology.

[37]  M. Matsui,et al.  Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression* , 1999, The Journal of Biological Chemistry.

[38]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[39]  C. Winterbourn,et al.  Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.

[40]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[41]  Benoit Nemery,et al.  Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. , 2003, Toxicology and applied pharmacology.

[42]  Y. Yoshioka,et al.  The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. , 2010, Biomaterials.

[43]  Monty Liong,et al.  Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. , 2008, ACS nano.

[44]  K. Landfester,et al.  Effect of hydrophilic comonomer and surfactant type on the colloidal stability and size distribution of carboxyl- and amino-functionalized polystyrene particles prepared by miniemulsion polymerization. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[45]  Sudipta Seal,et al.  Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. , 2009, ACS nano.

[46]  Yang Zhang,et al.  Template‐based modeling and free modeling by I‐TASSER in CASP7 , 2007, Proteins.

[47]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[48]  A. Surprenant,et al.  Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates , 2009, The EMBO journal.

[49]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[50]  Feng Zhang,et al.  Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding , 2010, Journal of The Royal Society Interface.

[51]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[52]  Jonas Baltrusaitis,et al.  Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles* , 2011, The Journal of Biological Chemistry.

[53]  J. Pounds,et al.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[54]  D. van der Spoel,et al.  Efficient docking of peptides to proteins without prior knowledge of the binding site , 2002, Protein science : a publication of the Protein Society.

[55]  David W. Ritchie,et al.  Ultra-fast FFT protein docking on graphics processors , 2010, Bioinform..

[56]  T. Syrovets,et al.  Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation. , 2001, Blood.

[57]  M. Karin,et al.  From death receptor to reactive oxygen species and c‐Jun N‐terminal protein kinase: the receptor‐interacting protein 1 odyssey , 2007, Immunological reviews.

[58]  Orlin D. Velev,et al.  In situ assembly of colloidal particles into miniaturized biosensors , 1999 .

[59]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[61]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[62]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[63]  Betty Y. S. Kim,et al.  Current concepts: Nanomedicine , 2010 .

[64]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[65]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[66]  F. Caruso,et al.  Nano- and Microengineering: 3-D Colloidal Photonic Crystals Prepared from Sub-μm-sized Polystyrene Latex Spheres Pre-Coated with Luminescent Polyelectrolyte/Nanocrystal Shells , 2000 .